We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Pramipexole Dihydrochloride Tablets 0.25mg (Rising, USA)
Section 19A approved medicine
Pramipexole Dihydrochloride Tablets 0.25mg (Rising, USA)
Section 19A approval holder
Reach Pharmaceuticals Pty Ltd ABN 25 623 897 183
Phone
0422 429 648
Approved until
Status
Current
Medicines in short supply/unavailable
APO-PRAMIPEXOLE pramipexole dihydrochloride monohydrate 0.25 mg tablet blister pack - ARTG 227667
SIMPRAL pramipexole dihydrochloride monohydrate 0.25 mg tablet blister pack - ARTG 173138
SIMIPEX pramipexole dihydrochloride monohydrate 0.25 mg tablet blister pack - ARTG 172018
SIFROL pramipexole dihydrochloride monohydrate 250 microgram tablet blister pack - ARTG 66484
SIMPRAL pramipexole dihydrochloride monohydrate 0.25 mg tablet blister pack - ARTG 173138
SIMIPEX pramipexole dihydrochloride monohydrate 0.25 mg tablet blister pack - ARTG 172018
SIFROL pramipexole dihydrochloride monohydrate 250 microgram tablet blister pack - ARTG 66484
Indication(s)
The treatment of signs and symptoms of idiopathic Parkinson's disease. It may be used as monotherapy or in combination with levodopa.
The symptomatic treatment of primary Restless Legs Syndrome.
Images
